GLP-1 agonists reduce hepatic steatosis primarily through weight loss, improved insulin sensitivity, and decreased hepatic glucose production and lipogenesis
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
DOI: 10.1016/j.physbeh.2017.04.017 Fitch, A., et al
Western blot analysis quantified protein expression levels, utilizing total protein extracts as well as nuclear and cytoplasmic fractions
However, since oral GLP-1s regulate blood sugar levels, this can effectively improve insulin sensitivity
A small 3.7V/4.2V LiPo Charger with a USB Type-C Plug, no cables needed